150 related articles for article (PubMed ID: 8007658)
21. Dmd(mdx-beta geo): a new allele for the mouse dystrophin gene.
Wertz K; Füchtbauer EM
Dev Dyn; 1998 Jun; 212(2):229-41. PubMed ID: 9626497
[TBL] [Abstract][Full Text] [Related]
22. Distribution of dystrophin and neurofilament protein in muscle spindles of normal and Mdx-dystrophic mice: an immunocytochemical study.
Nahirney PC; Ovalle WK
Anat Rec; 1993 Apr; 235(4):501-10. PubMed ID: 8465985
[TBL] [Abstract][Full Text] [Related]
23. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
24. The effects of hyperthyroidism on muscular dystrophy in the mdx mouse: greater dystrophy in cardiac and soleus muscle.
Anderson JE; Liu L; Kardami E
Muscle Nerve; 1994 Jan; 17(1):64-73. PubMed ID: 8264704
[TBL] [Abstract][Full Text] [Related]
25. Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: a potential role in calcium buffering and sarcolemmal stability.
Matsumura CY; Pertille A; Albuquerque TC; Santo Neto H; Marques MJ
Muscle Nerve; 2009 Feb; 39(2):167-76. PubMed ID: 19145649
[TBL] [Abstract][Full Text] [Related]
26. The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy.
Danko I; Chapman V; Wolff JA
Pediatr Res; 1992 Jul; 32(1):128-31. PubMed ID: 1635838
[TBL] [Abstract][Full Text] [Related]
27. Muscle development in mdx mutant mice.
Dangain J; Vrbova G
Muscle Nerve; 1984; 7(9):700-4. PubMed ID: 6543918
[TBL] [Abstract][Full Text] [Related]
28. The effects of altered metabolism (hypothyroidism) on muscle repair in the mdx dystrophic mouse.
McIntosh LM; Pernitsky AN; Anderson JE
Muscle Nerve; 1994 Apr; 17(4):444-53. PubMed ID: 8170492
[TBL] [Abstract][Full Text] [Related]
29. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation.
Karpati G; Pouliot Y; Zubrzycka-Gaarn E; Carpenter S; Ray PN; Worton RG; Holland P
Am J Pathol; 1989 Jul; 135(1):27-32. PubMed ID: 2672825
[TBL] [Abstract][Full Text] [Related]
30. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y
Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108
[TBL] [Abstract][Full Text] [Related]
31. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity.
Spencer MJ; Walsh CM; Dorshkind KA; Rodriguez EM; Tidball JG
J Clin Invest; 1997 Jun; 99(11):2745-51. PubMed ID: 9169505
[TBL] [Abstract][Full Text] [Related]
32. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
Schertzer JD; Ryall JG; Lynch GS
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
[TBL] [Abstract][Full Text] [Related]
33. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
[TBL] [Abstract][Full Text] [Related]
34. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
Lochmüller H; Petrof BJ; Pari G; Larochelle N; Dodelet V; Wang Q; Allen C; Prescott S; Massie B; Nalbantoglu J; Karpati G
Gene Ther; 1996 Aug; 3(8):706-16. PubMed ID: 8854096
[TBL] [Abstract][Full Text] [Related]
35. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
36. Muscle genome-wide expression profiling during disease evolution in mdx mice.
Marotta M; Ruiz-Roig C; Sarria Y; Peiro JL; Nuñez F; Ceron J; Munell F; Roig-Quilis M
Physiol Genomics; 2009 Apr; 37(2):119-32. PubMed ID: 19223608
[TBL] [Abstract][Full Text] [Related]
37. The short MCK1350 promoter/enhancer allows for sufficient dystrophin expression in skeletal muscles of mdx mice.
Larochelle N; Oualikene W; Dunant P; Massie B; Karpati G; Nalbantoglu J; Lochmuller H
Biochem Biophys Res Commun; 2002 Apr; 292(3):626-31. PubMed ID: 11922612
[TBL] [Abstract][Full Text] [Related]
38. Passive mechanical properties of maturing extensor digitorum longus are not affected by lack of dystrophin.
Wolff AV; Niday AK; Voelker KA; Call JA; Evans NP; Granata KP; Grange RW
Muscle Nerve; 2006 Sep; 34(3):304-12. PubMed ID: 16770793
[TBL] [Abstract][Full Text] [Related]
39. Dystrophic changes in mdx muscle regenerating from denervation and devascularization.
Anderson JE
Muscle Nerve; 1991 Mar; 14(3):268-79. PubMed ID: 2041548
[TBL] [Abstract][Full Text] [Related]
40. Muscle damage in mdx mice.
Jackson MJ; McArdle A; Edwards RH; Jones DA
Nature; 1991 Apr; 350(6320):664. PubMed ID: 2023630
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]